|
1
|
Bruder SP, Jaiswal N and Haynesworth SE:
Growth kinetics, self-renewal, and the osteogenic potential of
purified human mesenchymal stem cells during extensive
subcultivation and following cryopreservation. J Cell Biochem.
64:278–294. 1997. View Article : Google Scholar
|
|
2
|
Long MW, Robinson JA, Ashcraft EA and Mann
KG: Regulation of human bone marrow-derived osteoprogenitor cells
by osteogenic growth factors. J Clin Invest. 95:881–887. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taguchi Y, Yamamoto M, Yamate T, et al:
Interleukin-6-type cytokines stimulate mesenchymal progenitor
differentiation toward the osteoblastic lineage. Proc Assoc Am
Physicians. 110:559–574. 1998.PubMed/NCBI
|
|
4
|
Zhao K and Qin S: Bone tissue engineering
research progress. J Liaoning Med Univ. 1:382–384. 2011.(In
Chinese).
|
|
5
|
Carlo-Stella C and Gianni MA: Biology and
clinical applications of marrow mesenchymal stem cells. Pathol Biol
(Paris). 53:162–164. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kassem M: Mesenchymal stem cells:
biological characteristics and potential clinical applications.
Cloning Stem Cells. 6:369–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Okubo Y, Bessho K, Fujimura K, et al:
Osteoinduction by recombinant human bone morphogenetic protein-2 at
intramuscular, intermuscular, subcutaneous and intrafatty sites.
Int J Oral Maxillofac Surg. 29:62–66. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inao M, Mochida S, Matsui A, et al:
Japanese herbal medicine Inchin-ko-to as a therapeutic drug for
liver fibrosis. J Hepatol. 41:584–591. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu Z, Zeng R, Guo W and Lin H: Induction
and differentiation of bone marrow mesenchymal stem cells. J Clin
Rehabil Tissue Eng Res. 12:8561–8566. 2008.(In Chinese).
|
|
10
|
Pontikoglou C, Deschaseaux F, Sensebé L
and Papadaki HA: Bone marrow mesenchymal stem cells: biological
properties and their role in hematopoiesis and hematopoietic stem
cell transplantation. Stem Cell Rev. 7:569–589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia W, Xu R, Ye X, et al: Biological
appraisal of human bone marrow mesenchymal stem cells during
ex-vivo expansion. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 16:639–644.
2008.(In Chinese).
|
|
12
|
Yoo HJ, Yoon SS, Park S, et al: Production
and characterization of monoclonal antibodies to mesenchymal stem
cells derived from human bone marrow. Hybndoma (Larchmt). 24:92–97.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Weinreb M, Grosskopf A and Shir N: The
anabolic effect of PGE2 in rat bone marrow cultures is mediated via
the EP4 receptor subtype. Am J Physiol. 276:E376–E383.
1999.PubMed/NCBI
|
|
14
|
Kveiborg M, Flyvbjerg A, Eriksen EF and
Kassem M: 1,25-Dihydroxyvitamin D3 stimulates the production of
insulin-like growth-factor-binding proteins-2,-3 and -4 in human
bone marrow stromal cells. Eur J Endocrinol. 144:549–557. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tabin CJ: Retinoids, homeoboxes, and
growth factors: toward molecular models for limb development. Cell.
66:199–217. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gerhart TN, Kirker-Head CA, Kriz MJ, et
al: Healing segmental femoral defects in sheep using recombinant
human bone morphogenetic protein. Clin Orthop Relat Res.
293:317–326. 1993.PubMed/NCBI
|
|
17
|
Locklin RM, Williamson MC, Beresford JN,
Triffitt JT and Owen ME: In vitro effects of growth factors and
dexamethasone on rat marrow stromal cells. Clin Orthop Relat Res.
313:27–35. 1995.PubMed/NCBI
|
|
18
|
Pungitore CR, Ayub MJ, García M, et al:
Iridoids as allelochemicals and DNA polymerase inhibitors. J Nat
Prod. 67:357–361. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li YM, Li H and Li CR: Advance on chemical
compositions and pharmacology of Cornus officinalis. Acta
Academiae Medicinae CPAF. 6:74–75. 2010.
|
|
20
|
Wang W, Sun F and An Y: Morroniside
inhibits hydrogen peroxide-induced calcium overload and
cytotoxicity in SH-SY5Y neuroblastoma cells. Chin J Rehabil Theory
Pract. 3:115–117. 2009.
|
|
21
|
Zhang L, Li C and Zhao L: Effects of
cornel iridoid glycoside on nervous function and neuron damage in
focal cerebral ischemic rats. Chin J Rehabil Theory Pract.
3:110–113. 2007.
|
|
22
|
Javazon EH, Colter DC, Schwarz EJ and
Prockop DJ: Rat marow stromal cells are more sensitive to plating
density and expand more rapidly from single-cell-derived colonies
than human marrow stromal cells. Stem Cells. 19:219–225. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McCabe LR, Banerjee C, Kundu R, et al:
Developmental expression and activities of specific fos and jun
proteins are functionally related to osteoblast maturation: role of
Fra-2 and Jun D during differentiation. Endocrinology.
137:4398–4408. 1996.
|
|
24
|
Uludag H, D’Augusta D, Golden J, et al:
Implantation of recombinant human bone morphogenetic proteins with
biomaterial carriers: A correlation between protein
pharmacokinetics and osteoinduction in the rat ectopic model. J
Biomed Mater Res. 50:227–238. 2000. View Article : Google Scholar
|
|
25
|
Peng H, Wright V, Usas A, et al:
Synergistic enhancement of bone formation and healing by stem
cell-expressed VEGF and bone morphogenetic protein-4. J Clin
Invest. 110:751–759. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reddi AH: Bone morphogenetic proteins,
bone marrow stromal cells, and mesenchymal stem cells. Maureen Owen
revisited. Clin Orthop Relat Res. 313:115–119. 1995.PubMed/NCBI
|
